ABILIFY- aripiprazole tablet ABILIFY- aripiprazole solution ABILIFY- aripiprazole tablet, orally disintegrating ABILIFY- arip United States - English - NLM (National Library of Medicine)

abilify- aripiprazole tablet abilify- aripiprazole solution abilify- aripiprazole tablet, orally disintegrating abilify- arip

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea

OTSUKA GLUCOSE INJECTION 10% (20mL) (大塚糖液10％（20mL）) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

otsuka glucose injection 10% (20ml) (大塚糖液10％（20ml）)

otsuka pharmaceutical factory, inc. - purified glucose - injection

OTSUKA GLUCOSE INJECTION 5% (100mL) (大塚糖液5％（100mL）) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

otsuka glucose injection 5% (100ml) (大塚糖液5％（100ml）)

otsuka pharmaceutical factory, inc. - purified glucose - injection

Glucose Solution for injection 50 Tanzania - English - Tanzania Medicinces & Medical Devices Authority

glucose solution for injection 50

otsuka pharmaceutical india private limited, india - glucose anhydrous - solution for injection - 50

GLUCOSE INTRAVENOUS INFUSION BP 5% Singapore - English - HSA (Health Sciences Authority)

glucose intravenous infusion bp 5%

luen wah medical company (singapore) private limited - glucose anhydrous - injection - 50 g/1000 ml - glucose anhydrous 50 g/1000 ml

BUSULFEX busulfan 60mg/10mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

busulfex busulfan 60mg/10ml injection vial

otsuka australia pharmaceutical pty ltd - busulfan, quantity: 60 mg - injection - excipient ingredients: dimethylacetamide; macrogol 400 - busulfex is indicated for use in combination with cyclophosphamide, melphalan or fludarabine in conditioning prior to haematopoietic stem cell transplantation.

BFLUID Injection (1000mL) (ビーフリード輸液（1000mL）) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

bfluid injection (1000ml) (ビーフリード輸液（1000ml）)

otsuka pharmaceutical factory, inc. - vitamin b1; glucose; electrolytes; amino acid - injection

BFLUID Injection (500mL) (ビーフリード輸液（500mL）) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

bfluid injection (500ml) (ビーフリード輸液（500ml）)

otsuka pharmaceutical factory, inc. - vitamin b1; glucose; electrolytes; amino acid - injection

Abilify 9.75mg1.3ml solution for injection vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

abilify 9.75mg1.3ml solution for injection vials

otsuka pharmaceuticals (u.k. - aripiprazole - solution for injection - 7.5mg/1ml

Abilify Maintena 400mg powder and solvent for prolonged-release suspension for injection pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

abilify maintena 400mg powder and solvent for prolonged-release suspension for injection pre-filled syringes

otsuka pharmaceuticals (u.k. - aripiprazole - powder and solvent for suspension for injection - 400mg